Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: 'Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone' by Samson and Bonnotte.
- Berger CT Translational Immunology, Department of Biomedicine, University Basel, Basel, Switzerland Christoph.Berger@usb.ch.
- Daikeler T Clinic for Rheumatology, University Hospital Basel, Basel, Switzerland.
- 2019-05-31
Published in:
- Annals of the rheumatic diseases. - 2020
corticosteroids
giant cell arteritis
inflammation
treatment
Antibodies, Monoclonal, Humanized
Cross-Sectional Studies
Giant Cell Arteritis
Humans
Infections
Interleukin-6
Prednisone
Recurrence
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1136/annrheumdis-2019-215729
- PMID 31142475
- Persistent URL
- https://sonar.ch/global/documents/92762
Statistics
Document views: 27
File downloads:
- Full-text: 0